These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36188218)

  • 41. Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation.
    van der Goot AT; Zhu W; Vázquez-Manrique RP; Seinstra RI; Dettmer K; Michels H; Farina F; Krijnen J; Melki R; Buijsman RC; Ruiz Silva M; Thijssen KL; Kema IP; Neri C; Oefner PJ; Nollen EA
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14912-7. PubMed ID: 22927396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
    J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2.
    Jusof FF; Bakmiwewa SM; Weiser S; Too LK; Metz R; Prendergast GC; Fraser ST; Hunt NH; Ball HJ
    Int J Tryptophan Res; 2017; 10():1178646917735098. PubMed ID: 29051706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson's disease.
    Boros FA; Vécsei L
    Expert Opin Ther Targets; 2021 Oct; 25(10):877-888. PubMed ID: 34720020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
    Paccosi S; Cecchi M; Silvano A; Fabbri S; Parenti A
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3155-3163. PubMed ID: 32776284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
    Terai M; Londin E; Rochani A; Link E; Lam B; Kaushal G; Bhushan A; Orloff M; Sato T
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
    Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
    Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
    Dawood S; Bano S; Badawy AA
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias.
    Badawy AA
    Med Hypotheses; 2019 Oct; 131():109314. PubMed ID: 31443750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered Tryptophan Catabolism in Placentas From Women With Pre-eclampsia.
    Keaton SA; Heilman P; Bryleva EY; Madaj Z; Krzyzanowski S; Grit J; Miller ES; Jälmby M; Kalapotharakos G; Racicot K; Fazleabas A; Hansson SR; Brundin L
    Int J Tryptophan Res; 2019; 12():1178646919840321. PubMed ID: 31007529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.
    Triplett TA; Garrison KC; Marshall N; Donkor M; Blazeck J; Lamb C; Qerqez A; Dekker JD; Tanno Y; Lu WC; Karamitros CS; Ford K; Tan B; Zhang XM; McGovern K; Coma S; Kumada Y; Yamany MS; Sentandreu E; Fromm G; Tiziani S; Schreiber TH; Manfredi M; Ehrlich LIR; Stone E; Georgiou G
    Nat Biotechnol; 2018 Sep; 36(8):758-764. PubMed ID: 30010674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.
    Platten M; von Knebel Doeberitz N; Oezen I; Wick W; Ochs K
    Front Immunol; 2014; 5():673. PubMed ID: 25628622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comprehensive comparison of the metazoan tryptophan degrading enzymes.
    Yuasa HJ
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140247. PubMed ID: 31276825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of tryptophan metabolism in cancers and therapeutic implications.
    Liu XH; Zhai XY
    Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers.
    Hoffmann D; Dvorakova T; Stroobant V; Bouzin C; Daumerie A; Solvay M; Klaessens S; Letellier MC; Renauld JC; van Baren N; Lelotte J; Marbaix E; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):19-31. PubMed ID: 31806639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
    Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
    Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells.
    Cecchi M; Paccosi S; Silvano A; Eid AH; Parenti A
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy.
    Austin CJ; Rendina LM
    Drug Discov Today; 2015 May; 20(5):609-17. PubMed ID: 25478733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of IDO1 enzyme activity in normal and malignant tissues.
    Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA
    Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.